Live Breaking News & Updates on Geisinger Health Plans

Stay updated with breaking news from Geisinger health plans. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pennsylvania Insurers CVS and Geisinger to Cover OTC Birth Control,

Pennsylvania Insurers CVS and Geisinger to Cover OTC Birth Control,
hoodline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hoodline.com Daily Mail and Mail on Sunday newspapers.

United States , Michael Humphreys , Josh Shapiro , Pennsylvania Insurance Department , Shapiro Administration , Geisinger Health , Geisinger Health Plans , Governor Josh Shapiro , Governor Shapiro , Keystone State , Insurance Commissioner Michael Humphreys ,

Pennsylvania insurers cover over-the-counter birth control at no cost

Following recent state guidance, over-the-counter birth control is now being covered at no cost for select health plans, according to a release from Governor Josh Shapiro s office. ....

United States , Josh Shapiro , Geisinger Health , Pennsylvania Insurance Department , Governor Josh Shapiro , Geisinger Health Plans , Governor Shapiro , Cvs Health Plans , Geisinger Health Plans , Pennsylvania Governor Josh Shapiro , Pennsylvania News ,

It's Already Doubled in 2021, and This Healthcare Juggernaut Is Just Getting Started


Skin cancer detection company
Dermtech (NASDAQ:DMTK) has seen a spree of good news lately. The company is reimagining the way skin cancer is detected, using stickers rather than scalpels to remove cells for testing. With several factors pushing the stock to double so far this year, its ascent may be just beginning.
The clinical data for its melanoma detection sticker, which is called the Pigmented Lesion Assay (PLA), is promising, with the sticker demonstrating superiority to a traditional scalpel-wielding biopsy. Just how much better is it? Standard biopsies miss about 17% of melanoma cases; the PLA misses just 1%. It s also more efficient for every 25 biopsies performed, only one melanoma will be found, compared with one melanoma for every 2.7 PLA tests. All of this is a big win for patients but the positive news for this small cap doesn t stop there. ....

United States , Merritt Hawkins , Geisinger Health , National Comprehensive Cancer Network , Sciences Nasdaq , Pigmented Lesion Assay , Image Source , Blue Cross , Blue Shield , Geisinger Health Plans , Exact Sciences , ஒன்றுபட்டது மாநிலங்களில் , மெரிட் ஹாக்கின்ஸ் , கேய்சிங்கேர் ஆரோக்கியம் , தேசிய விரிவான புற்றுநோய் வலைப்பின்னல் , அறிவியல் நாஸ்டாக் , படம் மூல , நீலம் குறுக்கு , நீலம் கவசம் , கேய்சிங்கேர் ஆரோக்கியம் திட்டங்கள் , சரியான அறிவியல் ,